Treatment profile of patients with moderate-to-severe psoriasis included in the Turkish national registry PSR-TR

被引:0
|
作者
Onsun, N. [1 ]
Baskan, E. B. [2 ]
Dizman, D. [3 ]
Ozkaya, D. B. [1 ]
Erkilic, A. C. [4 ]
Ozarmagan, G. [5 ]
Gurer, M. A. [6 ]
机构
[1] Bezmi Alem Univ, Istanbul, Turkey
[2] Uludag Univ, Bursa, Turkey
[3] Bezmi Alem Univ, Istanbul, Turkey
[4] Yeditepe Univ, Istanbul, Turkey
[5] Istanbul Univ, Istanbul, Turkey
[6] Gazi Univ, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P042
引用
收藏
页码:E268 / E268
页数:1
相关论文
共 50 条
  • [1] Characteristics and risk profile of patients with psoriasis included in the Turkish national registry PSR-TR
    Onsun, N.
    Baskan, E. B.
    Dizman, D.
    Ozkaya, D. B.
    Erkilic, A. C.
    Ozarmagan, G.
    Gurer, M. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E268 - E268
  • [2] Patient profile of nonresponders to ustekinumab in moderate-to-severe psoriasis patients enrolled in the Corrona Psoriasis Registry
    van Voorhees, Abby S.
    Karki, Chitra
    Mason, Marc A.
    Harrold, Leslie R.
    Guo, Ning
    Guana, Adriana
    Tian, Haijun
    Herrra, Vivian
    Strober, Bruce E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB216 - AB216
  • [3] Influenza vaccination rate among patients with moderate-to-severe psoriasis in the German National Psoriasis Registry PsoBest
    Radtke, M. A.
    Rustenbach, S. J.
    Reusch, M.
    Augustin, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E160 - E161
  • [4] Tailored biological treatment for patients with moderate-to-severe psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
  • [5] Effectiveness of guselkumab among patients with moderate-to-severe plaque psoriasis in the Corrona Psoriasis Registry
    Armstrong, April W.
    Callis-Duffin, Kristina
    Fitzgerald, Timothy
    Teeple, Amanda
    Uy, Jonathan
    Olurinde, Mobolaji
    Rowland, Katelyn
    McLean, Robert R.
    Guo, Lin
    Shan, Ying
    Van Voorhees, Abby S.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB122 - AB122
  • [6] Tofacitinib for the treatment of moderate-to-severe psoriasis
    Chiricozzi, Andrea
    Faleri, Sara
    Saraceno, Rosita
    Bianchi, Luca
    Buonomo, Oreste
    Chimenti, Sergio
    Chimenti, Maria Sole
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
  • [7] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    [J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [8] Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
    Suarez-Farinas, Mayte
    Li, Katherine
    Fuentes-Duculan, Judilyn
    Hayden, Karen
    Brodmerkel, Carrie
    Krueger, James G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (11) : 2552 - 2564
  • [9] Pooled efficacy of infliximab for the treatment of patients with moderate-to-severe psoriasis
    Menter, A.
    Papp, K.
    Guzzo, C.
    Li, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 249 - 249
  • [10] Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
    Van Voorhees, Abby S.
    Mason, Marc A.
    Harrold, Leslie R.
    Guo, Ning
    Guana, Adriana
    Tian, Haijun
    Herrera, Vivian
    Strober, Bruce E.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (08) : 907 - 915